1. Zhu, Fen, Rui, Lixin. 2019. PRMT5 in gene regulation and hematologic malignancies. In Genes & diseases, 6, 247-257. doi:10.1016/j.gendis.2019.06.002. https://pubmed.ncbi.nlm.nih.gov/32042864/
2. Kryukov, Gregory V, Wilson, Frederick H, Ruth, Jason R, Hahn, William C, Garraway, Levi A. 2016. MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells. In Science (New York, N.Y.), 351, 1214-8. doi:10.1126/science.aad5214. https://pubmed.ncbi.nlm.nih.gov/26912360/
3. Mavrakis, Konstantinos J, McDonald, E Robert, Schlabach, Michael R, Stegmeier, Frank, Sellers, William R. 2016. Disordered methionine metabolism in MTAP/CDKN2A-deleted cancers leads to dependence on PRMT5. In Science (New York, N.Y.), 351, 1208-13. doi:10.1126/science.aad5944. https://pubmed.ncbi.nlm.nih.gov/26912361/
4. Stopa, Nicole, Krebs, Jocelyn E, Shechter, David. 2015. The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond. In Cellular and molecular life sciences : CMLS, 72, 2041-59. doi:10.1007/s00018-015-1847-9. https://pubmed.ncbi.nlm.nih.gov/25662273/
5. Yang, Liu, Ma, Da-Wei, Cao, Yue-Peng, Feng, Ji-Feng, Bao, Jun. 2021. PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression. In Theranostics, 11, 3742-3759. doi:10.7150/thno.53023. https://pubmed.ncbi.nlm.nih.gov/33664859/
6. Liu, Ming, Yao, Bing, Gui, Tao, Ju, Junyi, Zhao, Quan. 2020. PRMT5-dependent transcriptional repression of c-Myc target genes promotes gastric cancer progression. In Theranostics, 10, 4437-4452. doi:10.7150/thno.42047. https://pubmed.ncbi.nlm.nih.gov/32292506/
7. Sloan, Shelby L, Brown, Fiona, Long, Mackenzie, Baiocchi, Robert A, Alinari, Lapo. . PRMT5 supports multiple oncogenic pathways in mantle cell lymphoma. In Blood, 142, 887-902. doi:10.1182/blood.2022019419. https://pubmed.ncbi.nlm.nih.gov/37267517/
智鼠故事 
